• Rapid detection
Simultaneous detection of all three pathogens completed with an innovative and exclusive one-step method. RNA processing completed in 3 minutes, with sample-to-results in 35 minutes.
• One-tube multiplex testing
A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses.
• Accurate and safe
Full coverage of genes, multiplex detection, and multiple guarantees, among which the SARS-CoV-2 test has been approved by the FDA.
• Multiple monitoring
Operation quality control includes three internal standards: positive control, negative control, and human DNA gene sequence.
• Unique technology
Nanobody molecular locking technology (MoLock) improves sensitivity and specificity.
• High sensitivity
Sensitivity reaches 5 copies/reaction.
• CE Certification
The Respiratory Triplex Panel Test Kit for COVID-19 and influenza A/B detects multiple pathogens in one tube, accurately distinguishes COVID-19 from HBV viruses, assists doctors in diagnosing disease, and provide a reliable basis for epidemic prevention and control and clinical treatment.